Israel - English - Ministry of Health

rafa laboratories ltd - phenoxymethylpenicillin as potassium - caplets - phenoxymethylpenicillin as potassium 500 mg - phenoxymethylpenicillin - phenoxymethylpenicillin - for susceptible microorganisms. to treat group a haemolytic infections of the upper respiratory tract using a twice daily regimen (1 g. bid in adults, 0.5 g bid in children).

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin benzathine, quantity: 40.27 mg/ml (equivalent: phenoxymethylpenicillin, qty 30 mg/ml) - oral liquid, suspension - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; butylated hydroxyanisole; polysorbate 80; xanthan gum; sucrose; purified water; sodium citrate dihydrate; potassium sorbate; citric acid; flavour - treatment of mild to moderately severe infections due to penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note: oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - phenoxymethylpenicillin benzathine -

Namibia - English - Namibia Medicines Regulatory Council

milan laboratories (india) pvt ltd - phenoxymethylpenicillin potassium - powder for reconstitution - each 5ml of reconstituted solution contains phenoxymethylpenicillin potassium bp equivalent to phenoxymethylpenicillin 250,0 mg

Namibia - English - Namibia Medicines Regulatory Council

milan laboratories (india) pvt ltd - phenoxymethylpenicillin potassium - powder for reconstitution - each 5ml of reconstituted solution contains phenoxymethylpenicillin potassium bp equivalent to phenoxymethylpenicillin 125,0 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - phenoxymethylpenicillin potassium - oral solution - 50mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phenoxymethylpenicillin, quantity: 250 mg - capsule, hard - excipient ingredients: brilliant blue fcf; magnesium stearate; titanium dioxide; erythrosine; sunset yellow fcf; carbon black; gelatin; indigo carmine; allura red ac; quinoline yellow aluminium lake; iron oxide black; sd alcohol 3-a - treatment of mild to moderately severe infections due to penicillin v sensitive micro-organisms. therapy should be guided by bacteriological studies ( including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteraemia, pericarditis, meningitis and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v: streptococcal infections( without bacteraemia). mild to moderate infections of the upper respiratory tract, scarlet fever and mild erysipelas. note: streptococci in groups a,c,g,h,l and m are very sensitive to penicillin. other groups, including group d (enterococcus) are resistant. pneumococcal infections. mild to moderately severe infections of the respiratory tract. staphylococcal infections-penicillin v sensitive. mild infections of the skin and soft tissues. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin v, emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections. fusospirochetosis (vincent's gingivitis and pharyngitis)-mild to moderately severe infections of the oropharynx usually respond to therapy with oral penicillin. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin v, emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections. fusospirochetosis( vincent's gingivitis and pharyngitis)-mild to moderately severe infections of the oropharynx usually respond to therapy with oral penicillin. note; necessary dental care should be accomplished in infections involving the gum tissue. medical conditions in which oral penicillin therapy is indicated as prophylaxis: for the prevention of recurrence following rheumatic fever and/or chorea-prophylaxis with oral penicillin on a continuing basis has proven bacterial endocarditis in patients with congenital and/or rheumatic heart lesions who are to undergo dental procedures or minor upper respiratory tract surgery or instrumentation. prophylaxis should be instituted on the day of the procedure and for 2 or more days following. patients who have a past history of rheumatic fever and are receiving continuous prophylaxis may harbour increased numbers of penicillin-resistant organisms; use of another prophylactic anti-infective agent should be considered. if penicillin is to be used in these patients at surgery, penicillin may be re-instituted as a prophylactic measure against the hazards of surgically induced bacteraemia. note: oral penicillin should not be used as a adjunctive prophylaxis for genito-urinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy and complications of childbirth.

Australia - English - Department of Health (Therapeutic Goods Administration)

mylan health pty ltd - phenoxymethylpenicillin potassium -

Australia - English - Department of Health (Therapeutic Goods Administration)

mylan health pty ltd - phenoxymethylpenicillin potassium -

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin potassium, quantity: 277.18 mg (equivalent: phenoxymethylpenicillin, qty 250 mg) - capsule, hard - excipient ingredients: magnesium stearate; gelatin; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified water - indications as at 22 december 1998:when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recent streptococcal infections including the prevention of recurrence following rhematic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/pr congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth.